Search Results

Loureirin B 5mg 5mg  | Purity Not Available

Adooq Bioscience

Loureirin B, an essential component of Sanguis Draxonis, inhibits Kv1.3 channel and suppresses cytokine release from Jurkat T cells.

More Information Supplier Page

Loureirin B 25mg 25mg  | Purity Not Available

Adooq Bioscience

Loureirin B, an essential component of Sanguis Draxonis, inhibits Kv1.3 channel and suppresses cytokine release from Jurkat T cells.

More Information Supplier Page

Loureirin B 10mg 10mg  | Purity Not Available

Adooq Bioscience

Loureirin B, an essential component of Sanguis Draxonis, inhibits Kv1.3 channel and suppresses cytokine release from Jurkat T cells.

More Information Supplier Page

Licochalcone C 50mg 50mg  | Purity Not Available

Adooq Bioscience

Licochalcone C was synthesized from commercially available 2,4-dihydroxybenzaldehde by using regioselective Al2O3-mediated C-prenylation followed by conventional Claisen-Schmidt condensation in basic condition.

More Information Supplier Page

Licochalcone C 25mg 25mg  | Purity Not Available

Adooq Bioscience

Licochalcone C was synthesized from commercially available 2,4-dihydroxybenzaldehde by using regioselective Al2O3-mediated C-prenylation followed by conventional Claisen-Schmidt condensation in basic condition.

More Information Supplier Page

Licochalcone C 10mg 10mg  | Purity Not Available

Adooq Bioscience

Licochalcone C was synthesized from commercially available 2,4-dihydroxybenzaldehde by using regioselective Al2O3-mediated C-prenylation followed by conventional Claisen-Schmidt condensation in basic condition.

More Information Supplier Page